MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today provides shareholders a ...

Oversubscribed $225 million concurrent private investment in public equity ("PIPE") with available cash to the combined ...

Claude Science, Anthropic’s new AI research workbench, launched in beta July 1 for all paid subscribers — no enterprise vetting required. The platform uses multi-agent orchestration across 60-plus ...

LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive ...

Advances strategic shift toward a disciplined research model prioritizing external innovation to accelerate rare disease pipeline growth- ...

Explore the evolving landscape of male contraception, including novel nonhormonal pills and injectable hydrogels in clinical ...

Isaacman will announce the next round of lunar lander mission awards Tuesday at 2:30 p.m. ET, as Blue Origin rebuilds its ...

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing ...

Diranersen presentation will feature Phase 2 CELIA data in early Alzheimer's disease, including clinical, biomarker and safety results for Biogen's investigational tau-targeting ASO, following topline ...

BingX Partners with Save the Children to Support Children at Risk in Western Balkans The new partnership will support migrant ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients ...

Advances strategic shift toward a disciplined research model prioritizing external innovation to accelerate rare disease pipeline growth- -Completes enrollment in Phase 3 ALPHA-ORBIT for navenibart ...